Enovix Corporation filed a Form S-3 shelf registration statement with the U.S. Securities and Exchange Commission on November 2, 2026, seeking to register up to $500,000,000 in common stock, preferred stock, debt securities, and warrants.

Key Highlights

  • Maximum aggregate offering: The registration covers up to $500,000,000 of securities in any combination of common stock, preferred stock, debt securities, and warrants.
  • Shelf registration process: Securities may be offered and sold from time to time on a continuous or delayed basis under Rule 415 of the Securities Act of 1933.
  • Last reported share price: The filing states that on October 30, 2026, the last reported sale price of Enovix common stock was $3.15 per share.
  • Listing: The company's common stock is listed on the Nasdaq Global Select Market under the trading symbol "ENVX," according to the filing.
  • Filer classification: Enovix identified itself as a large accelerated filer in the registration statement.
  • Agent for service: Ryan Benton, Interim Chief Executive Officer and Chief Financial Officer, is named as the agent for service in the filing.

Enovix Registers Up to $500M in Securities via Shelf Prospectus Filed November 2026

Enovix Corporation (NASDAQ:ENVX) filed a Form S-3 registration statement on November 2, 2026, using what the filing describes as a "shelf" registration process under the Securities Act of 1933. Under this structure, the company disclosed that it "may, from time to time, offer and sell common stock and preferred stock, various series of debt securities and/or warrants to purchase any of such securities, either individually or in combination with other securities, in one or more offerings, up to a total dollar amount of $500,000,000."

According to the filing, the base prospectus does not specify the terms of any individual offering. Instead, the company stated it will provide a prospectus supplement containing more specific information each time it sells any type or series of securities under the shelf. The filing also notes that the company may authorize free writing prospectuses in connection with specific offerings, and that any such materials "may also add, update or change information contained in this prospectus."

The filing indicates that securities may be sold "directly by us to investors, through agents designated from time to time or to or through underwriters or dealers." Names of agents or underwriters, applicable fees, commissions, discounts, and overallotment options, as well as the price to the public and net proceeds, will be set forth in the applicable prospectus supplement. The registration statement notes that it is subject to completion and that the preliminary prospectus "is not an offer to sell these securities." The company is incorporated in Delaware and headquartered at 3501 W. Warren Avenue, Fremont, California 94538.

What Was Disclosed

Enovix Corporation filed a Form S-3 shelf registration statement on November 2, 2026, covering up to $500,000,000 in mixed securities. Specific offering terms, pricing, and distribution details will be provided in future prospectus supplements as individual offerings occur.